PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

2017: Medical Game Changers Beckon

The State of Market Insights in Pharma

Research Responses to Patient Privacy Concerns

Forecast
'Cures' Challenges and Communication Changes Ahead for Pharma
Health reform, pricing pressures will shape drug marketing and development in 2017, writes Jill Wechsler
/Read more/
Advertisement
From Big Data to Measurable Outcomes: Success with Value-Based Contracts
Live Webinar: Tuesday, January 12 at 3:00pm EST
Register now
Forecast
Pharma and Europe 2017: Greater Uncertainties
2016 has been the year of the unpredictable — and the uncertainties this has generated will multiply and dominate the agenda in Europe in 2017, writes Reflector
/Read more/
Advertisement
Personalized medicine: Commercializing drugs with companion diagnostics
On Demand
Learn more
Forecast
Pharma M&A Market Challenges and Opportunities 2017
For ethical pharma companies, there continues to be a wide variety of tools to acquire revenues and pipeline drugs, but the valuations are challenging, writes Peter Young
/Read more/
Manufacturing
Going to the Edge
How life sciences companies can institute a manufacturing Excellence program in their global product strategies—with the goal of delivering competitive advantage, at lower cost
/Read more/
Calendar
/ February 08–09, 2017: Speaker Programs 2017 /
Philadelphia, PA
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ April 26–28, 2017: CBI's 14th Annual Pharmaceutical Compliance Congress /
WASHINGTON, DC
/ June 6–7, 2017: Pharmaceutical Compliance Congress Canada /
Toronto, Canada
/ 20–22 June 2017: EphMRA Annual Conference 2017 /
Amsterdam, The Netherlands
 
Industry update
//Dr. Pamela Stanley, Professor of Cell Biology at Albert Einstein College of Medicine, and Michel Disco, Associate Clinical Professor of Pharmacy Practice and Administrative Sciences at the University of New Mexico College of Pharmacy, have been selected to join the Education Board at the American Health Council (New York, NY).//CURE Pharmaceutical (Oxnard, CA) appointed William Yuan and Charles Berman to its board of directors.//Canada's Cancer Research Society announced the appointment of Max Fehlmann as its new President and Chief Executive Officer, effective January 16, 2017.//AMAG Pharmaceuticals (Waltham, MA) announced that Brian Kelley, former president and chief executive officer of Keurig Green Mountain, Inc., has been elected to its board of directors, effective December 20, 2016.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com